Welcome to Our Medtech Talk Podcast Channel

Too often we define the Medtech sector by the number of dollars raised, IPOs helped or companies sold. But the focus neglects the very foundation of the sector - the People. Join the Medtech Talk Podcast each week to hear from entrepreneurs, investors and executives who spend their days developing the tools that make sick people well and health care more efficient.

How Vascular Solutions Beat the DOJ & What Medtech Executives Need to Know to Do the Same

May 26, 2016

After five years and $25 million, Vascular Solutions CEO Howard Root watched a jury confirm what he knew all along. His company had done nothing wrong. In this interview, Root and Mark Duval, who is advising companies in this area but didn’t work with Vascular Solutions, explain what all this means for Medtech executives.

Howard Root

Retired CEO

Vascular Solutions

Howard Root is the retired Chief Executive Officer of Vascular Solutions, Inc., a company he founded in 1997, took public in 2000 and grew into a worldwide medical device company that he sold to Teleflex in February 2017 for $1 billion. Over the company’s 20 years, Howard led Vascular Solutions in inventing, developing and launching over 100 new medical devices used to improve the lives of patients suffering from cardiovascular disease. The motivation behind the sale of Vascular Solutions and Howard’s voluntary early retirement is a true-life legal nightmare that is detailed in Howard’s book: Cardiac Arrest: Five Heart-Stopping Years as a CEO on the Feds’ Hit-List.